Market cap
$935.1B
Price as of
2026-10-29
Latest filing
8-K · 2026-10-20
Alerts
8
Price$180.65 -0.41% 3M daily closessample
190.75171.65
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral
Latest events
Filings, trades, FDA; newest first- Oct 23INS
- Oct 20SEC
- Oct 12INS
- Oct 02SEC
- Sep 28INS
- Sep 21SEC
- Sep 14INS
- Sep 09INS
Company facts
SEC EDGAR registration- Name
- Biohaven Ltd.
- Sector
- Biotechnology
- Industry
- Biotechnology
- Smart-money score
- +47sample, -100 to +100
- Reporting currency
- USD
Who is positioning in BHVN
sample- Insiders
- 34 insider transactions over 90 days, net selling, $118.9M
- Congress
- 2 members traded over 90 days
- Institutions · 13F
- 28 funds hold $10.0B
- Activists · 13D/G
- No 13D/13G activist filings on record
How are the fundamentals trending?
sample, by period endRevenue$33.5B +11.9% y/y
Q4 2024Q3 2026
Inventory$19.9B +4.5% y/y
Q4 2024Q3 2026
Accounts receivable$15.1B +9.3% y/y
Q4 2024Q3 2026
Total debt$40.3B +7.7% y/y
Q4 2024Q3 2026
Peers
sample- Sample peer A
- $306.8B -12.0% 3M
- Sample peer B
- $720.9B -3.1% 3M
- Sample peer C
- $758.9B +3.2% 3M
- Sample peer D
- $827.6B -2.3% 3M
- Sample peer E
- $103.6B +0.8% 3M